morpholinoanthracycline mx2 has been researched along with irinotecan in 1 studies
Studies (morpholinoanthracycline mx2) | Trials (morpholinoanthracycline mx2) | Recent Studies (post-2010) (morpholinoanthracycline mx2) | Studies (irinotecan) | Trials (irinotecan) | Recent Studies (post-2010) (irinotecan) |
---|---|---|---|---|---|
53 | 15 | 0 | 8,002 | 1,885 | 3,752 |
Protein | Taxonomy | morpholinoanthracycline mx2 (IC50) | irinotecan (IC50) |
---|---|---|---|
Solute carrier family 22 member 2 | Homo sapiens (human) | 2.7 | |
Interstitial collagenase | Homo sapiens (human) | 6.06 | |
Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 1.556 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 3.171 | |
Acetylcholinesterase | Homo sapiens (human) | 1.827 | |
Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.9 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 4.7667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ohnishi, K; Ohno, R | 1 |
1 review(s) available for morpholinoanthracycline mx2 and irinotecan
Article | Year |
---|---|
[New antitumor drugs for malignant lymphoma: a review].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carubicin; Clinical Trials, Phase II as Topic; Female; Humans; Irinotecan; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Piperazines | 1994 |